Skip to main content

Advertisement

Log in

The Significance of Preoperative Chemotherapy in Evaluation of Recurrent Soft Tissue Liposarcoma Necrosis

  • Research
  • Published:
Pathology & Oncology Research

Abstract

To investigate the effect of preoperative induction chemotherapy on treatment of recurrent liposarcoma. 21 patients with recurrent liposarcoma received the treatment of preoperative intra-arterial chemotherapy and surgical resection. Intra-arterial chemotherapy was given by subcutaneous implantable drug delivery system with infusion of cisplatin and doxorubicin followed by caffeine. After treatment, patients were followed up for 39 months. The liposarcoma changes in CT imaging were observed in 18 cases and there were 15 cases with medium or severe pathological changes caused by chemotherapy. At the end of the postoperative follow-up of 39 months, liposarcoma reoccurred locally in 2 cases; pulmonary metastasis occurred in 1 case and death in 3 cases. Preoperative intra-arterial chemotherapy is effective for highly malignant tumors such as recurrent liposarcoma and the judgment of prognosis is based on the postoperative pathological changes of such tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Enzinger FM, Weiss SW (1988) Soft tissue tumors. Mosby St. Louis 346–382

  2. Mentzel T, Fletcher CD (1995) Lipomatous tumours of soft tissues: an update. Virchows Arch 427:353–363

    Article  PubMed  CAS  Google Scholar 

  3. Oliveira AM, Nascimento AG (2001) Pleomorphic liposarcoma. Semin Diagn Pathol 18:274–285

    PubMed  CAS  Google Scholar 

  4. Gebhard S, Coindre JM, Michels JJ, Terrier P, Bertrand G, Trassard M, Taylor S, Chateau MC, Marques B, Picot V, Guillou L (2002) Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 26:601–616

    Article  PubMed  Google Scholar 

  5. Zhang RM, Liu YW (2003) The chemotherapy of soft tissue sarcoma. Chin J Bone Tumor Bone Dis 2(3):181–185

    Google Scholar 

  6. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92(3):205–216

    Article  PubMed  CAS  Google Scholar 

  7. Rosen G, Caparros B, Huvos AG et al (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of Postoperativea-djuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. J Cancer 49(6):1221–1230

    Article  CAS  Google Scholar 

  8. DeLaney TF, Spiro IJ, Suit HD et al (2003) Neoadjuvant chemotherapy and radiotherapy for large extremity soft tissue sarcomas. Int J Radiat Oncol Biol Phys 56:1117–1127

    Article  PubMed  Google Scholar 

  9. Said Basly M, Khouni H, Dridi M (2009) Retroperitoneal liposarcoma. Tunis Med 87(8):552–554

    PubMed  Google Scholar 

  10. Chung PW, Deheshi BM, Ferguson PC (2009) Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas. Cancer 115(14):3254–3261

    Article  PubMed  Google Scholar 

  11. Shaerf DA, Mann B, Alorjani M et al (2011) High-grade intra-articular liposarcoma of the knee. Skeletal Radiol 40(3):363–365

    Article  PubMed  Google Scholar 

  12. Illuminati G, Ceccanei G, Pacilè MA et al (2010) Surgical outcomes for liposarcoma of the lower limbs with synchronous pulmonary metastases. J Surg Oncol 102(7):827–831

    Article  PubMed  Google Scholar 

  13. Han HH, Choi KH, Kim DS et al (2010) Retroperitoneal giant liposarcoma. Korean J Urol 51(8):579–582

    Article  PubMed  Google Scholar 

  14. Ozaki R, Hamada K, Emori M et al (2010) Limb salvage operation using intraoperative extracorporeal autogenous irradiated bone and tendon graft for myxoid liposarcoma on dorsum of foot. Foot (Edinb) 20(2–3):90–95

    Google Scholar 

  15. Endo M (2010) Musculoskeletal tumor. III. Chemotherapy of liposarcoma–the current status of chemotherapy and new findings in clinical trials of novel drugs. Gan to kagaku ryoho. Cancer & chemotherapy 37(3):434–438

    Google Scholar 

  16. Casali PG, Blay JY (2010) ESMO/CONTICANET/EUROBONET Consensus Panel of experts. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v198–v203

    Article  PubMed  Google Scholar 

  17. Picci P (2000) Adjuvant chemotherapy for extremity soft-tissue sarcomas in adults. Curr Oncol Rep 2:502–507

    Article  PubMed  CAS  Google Scholar 

  18. Patel SR, Burgess MA, Plager C, Papadopoulos NE, Linke KA, Benjamin RS (1994) Myxoid liposarcoma. Experience with chemotherapy. Cancer 74(4):1265–1269

    Article  PubMed  CAS  Google Scholar 

  19. Mankin HJ, Hornicek FJ (2005) Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control 12(1):5–21

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Dingfeng Li or Yanjun Zeng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cui, Q., Li, D., Zhang, J. et al. The Significance of Preoperative Chemotherapy in Evaluation of Recurrent Soft Tissue Liposarcoma Necrosis. Pathol. Oncol. Res. 18, 629–633 (2012). https://doi.org/10.1007/s12253-011-9487-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-011-9487-3

Keywords

Navigation